| Financial Year |
March 31 2023 |
| Monetary Funds |
600,472,073.32 |
| Held-for-trading Financial Assets |
126,545,384.83 |
| Notes Receivable |
31,135,742.41 |
| Accounts Receivable |
1,117,694,771.25 |
| Advances to Suppliers |
44,362,404.58 |
| Other Receivables |
90,684,024.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
415,608,665.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,682,128.00 |
| Other Current Assets |
35,512,028.48 |
| Total Current Assets |
2,562,959,900.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
376,608,146.66 |
| Investment Properties |
328,950,687.81 |
| Fixed Assetes |
1,059,236,218.59 |
| Under-construction Projects |
450,468,266.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
163,986,570.42 |
| R&D expenses |
-- |
| Goodwill |
2,049,178.35 |
| Long-Term Deferred and Prepaid Expenses |
18,741,368.47 |
| Deferred Income Tax Assets |
28,034,950.42 |
| Other Non-Current Assets |
3,534,570.62 |
| Sub-Total of Non-Current Assets |
3,468,819,790.48 |
| Total Assets |
6,031,779,691.15 |
| Short-Term Loans |
123,674,467.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,230,918.33 |
| Accounts Payable |
929,687,211.46 |
| Accounts Received In Advance |
504,996.82 |
| Employee Compensation Payable |
98,465,490.06 |
| Taxes Payable |
22,368,619.73 |
| Interest Payable |
-- |
| Dividend Payable |
1,882,597.62 |
| Other payables |
217,716,204.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
95,024,544.33 |
| Other Current Liabilities |
6,911,541.53 |
| Sub-Total of Current Liabilities |
1,628,806,283.28 |
| Long-term Loans |
600,180,676.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,053,810.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
758,695,101.14 |
| Total Liabilities |
2,387,501,384.42 |
| Paid-In Capital(Or Share Stock) |
1,027,527,102.00 |
| Capital Surplus |
1,580,313,348.55 |
| Surplus Reserve |
223,109,159.27 |
| LESS:Treasury Stock |
105,990,804.86 |
| Undistributed Profits |
628,935,567.11 |
| Minority Stockholder's Interest |
320,945,928.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,323,332,378.08 |
| Owner's Equity（Stockholder's Equity） |
3,644,278,306.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,031,779,691.15 |
